vs

Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Tarsus Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($151.7M vs $104.1M, roughly 1.5× GRID DYNAMICS HOLDINGS, INC.). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — -1.4% vs -5.5%, a 4.1% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 3.7%). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 12.0%).

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

GDYN vs TARS — Head-to-Head

Bigger by revenue
TARS
TARS
1.5× larger
TARS
$151.7M
$104.1M
GDYN
Growing faster (revenue YoY)
TARS
TARS
+124.7% gap
TARS
128.4%
3.7%
GDYN
Higher net margin
GDYN
GDYN
4.1% more per $
GDYN
-1.4%
-5.5%
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
12.0%
GDYN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GDYN
GDYN
TARS
TARS
Revenue
$104.1M
$151.7M
Net Profit
$-1.5M
$-8.4M
Gross Margin
34.8%
Operating Margin
61.7%
-5.3%
Net Margin
-1.4%
-5.5%
Revenue YoY
3.7%
128.4%
Net Profit YoY
-150.6%
63.8%
EPS (diluted)
$-0.02
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDYN
GDYN
TARS
TARS
Q1 26
$104.1M
Q4 25
$106.2M
$151.7M
Q3 25
$104.2M
$118.7M
Q2 25
$101.1M
$102.7M
Q1 25
$100.4M
$78.3M
Q4 24
$100.3M
$66.4M
Q3 24
$87.4M
$48.1M
Q2 24
$83.0M
$40.8M
Net Profit
GDYN
GDYN
TARS
TARS
Q1 26
$-1.5M
Q4 25
$306.0K
$-8.4M
Q3 25
$1.2M
$-12.6M
Q2 25
$5.3M
$-20.3M
Q1 25
$2.9M
$-25.1M
Q4 24
$4.5M
$-23.1M
Q3 24
$4.3M
$-23.4M
Q2 24
$-817.0K
$-33.3M
Gross Margin
GDYN
GDYN
TARS
TARS
Q1 26
34.8%
Q4 25
34.0%
Q3 25
33.3%
Q2 25
34.1%
Q1 25
36.8%
Q4 24
36.9%
Q3 24
37.4%
Q2 24
35.6%
Operating Margin
GDYN
GDYN
TARS
TARS
Q1 26
61.7%
Q4 25
0.5%
-5.3%
Q3 25
-0.2%
-12.2%
Q2 25
-0.1%
-21.6%
Q1 25
-2.0%
-33.5%
Q4 24
1.3%
-36.8%
Q3 24
2.4%
-52.3%
Q2 24
0.0%
-81.6%
Net Margin
GDYN
GDYN
TARS
TARS
Q1 26
-1.4%
Q4 25
0.3%
-5.5%
Q3 25
1.1%
-10.6%
Q2 25
5.2%
-19.8%
Q1 25
2.9%
-32.1%
Q4 24
4.5%
-34.8%
Q3 24
4.9%
-48.7%
Q2 24
-1.0%
-81.6%
EPS (diluted)
GDYN
GDYN
TARS
TARS
Q1 26
$-0.02
Q4 25
$0.01
$-0.17
Q3 25
$0.01
$-0.30
Q2 25
$0.06
$-0.48
Q1 25
$0.03
$-0.64
Q4 24
$0.06
$-0.57
Q3 24
$0.05
$-0.61
Q2 24
$-0.01
$-0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDYN
GDYN
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$327.5M
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$530.1M
$343.4M
Total Assets
$605.0M
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDYN
GDYN
TARS
TARS
Q1 26
$327.5M
Q4 25
$342.1M
$417.3M
Q3 25
$338.6M
$401.8M
Q2 25
$336.8M
$381.1M
Q1 25
$325.5M
$407.9M
Q4 24
$334.7M
$291.4M
Q3 24
$231.3M
$317.0M
Q2 24
$256.0M
$323.6M
Total Debt
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
$72.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Q2 24
$71.6M
Stockholders' Equity
GDYN
GDYN
TARS
TARS
Q1 26
$530.1M
Q4 25
$542.1M
$343.4M
Q3 25
$537.7M
$335.1M
Q2 25
$532.2M
$332.6M
Q1 25
$517.4M
$342.5M
Q4 24
$517.8M
$224.5M
Q3 24
$400.2M
$237.5M
Q2 24
$388.4M
$252.2M
Total Assets
GDYN
GDYN
TARS
TARS
Q1 26
$605.0M
Q4 25
$612.9M
$562.2M
Q3 25
$613.2M
$534.6M
Q2 25
$608.9M
$495.0M
Q1 25
$590.9M
$500.8M
Q4 24
$592.2M
$377.0M
Q3 24
$477.3M
$376.3M
Q2 24
$443.6M
$376.8M
Debt / Equity
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDYN
GDYN
TARS
TARS
Operating Cash FlowLast quarter
$19.3M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
8.6%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
$9.9M
$19.3M
Q3 25
$7.0M
$18.3M
Q2 25
$14.4M
$-29.4M
Q1 25
$9.4M
$-20.7M
Q4 24
$7.1M
$-22.2M
Q3 24
$9.2M
$-8.7M
Q2 24
$10.7M
$-14.4M
Free Cash Flow
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
$6.1M
$13.0M
Q3 25
$2.9M
$16.3M
Q2 25
$10.2M
$-30.4M
Q1 25
$6.0M
$-21.2M
Q4 24
$4.4M
$-22.3M
Q3 24
$5.9M
$-8.9M
Q2 24
$8.0M
$-15.4M
FCF Margin
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
5.7%
8.6%
Q3 25
2.8%
13.8%
Q2 25
10.1%
-29.6%
Q1 25
6.0%
-27.1%
Q4 24
4.4%
-33.5%
Q3 24
6.8%
-18.6%
Q2 24
9.7%
-37.8%
Capex Intensity
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
3.6%
4.2%
Q3 25
3.9%
1.6%
Q2 25
4.1%
1.0%
Q1 25
3.3%
0.8%
Q4 24
2.6%
0.1%
Q3 24
3.7%
0.6%
Q2 24
3.2%
2.5%
Cash Conversion
GDYN
GDYN
TARS
TARS
Q1 26
Q4 25
32.34×
Q3 25
5.92×
Q2 25
2.73×
Q1 25
3.21×
Q4 24
1.56×
Q3 24
2.15×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons